These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26606739)

  • 1. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection.
    Waidely E; Al-Yuobi AR; Bashammakh AS; El-Shahawi MS; Leblanc RM
    Analyst; 2016 Jan; 141(1):36-44. PubMed ID: 26606739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
    Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
    Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological tumor markers of hepatocellular carcinoma: a meta-analysis.
    Hussein TD
    Int J Biol Markers; 2015 Feb; 30(1):e32-42. PubMed ID: 25450646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.
    Hadziyannis E; Sialevris K; Georgiou A; Koskinas J
    Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
    Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum markers of hepatocellular carcinoma.
    Malaguarnera G; Giordano M; Paladina I; Berretta M; Cappellani A; Malaguarnera M
    Dig Dis Sci; 2010 Oct; 55(10):2744-55. PubMed ID: 20339916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
    Nakao A; Virji A; Iwaki Y; Carr B; Iwatsuki S; Starzl E
    Hepatogastroenterology; 1991 Oct; 38(5):450-3. PubMed ID: 1722483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
    Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present and future possibilities for early diagnosis of hepatocellular carcinoma.
    Stefaniuk P; Cianciara J; Wiercinska-Drapalo A
    World J Gastroenterol; 2010 Jan; 16(4):418-24. PubMed ID: 20101765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced detection of hepatocellular carcinoma.
    el-Houseini ME; Mohammed MS; Elshemey WM; Hussein TD; Desouky OS; Elsayed AA
    Cancer Control; 2005 Oct; 12(4):248-53. PubMed ID: 16258497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for Hepatocellular Carcinoma (HCC): An Update.
    Li D; Satomura S
    Adv Exp Med Biol; 2015; 867():179-93. PubMed ID: 26530367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellualar carcinoma serum markers.
    Bertino G; Ardiri A; Malaguarnera M; Malaguarnera G; Bertino N; Calvagno GS
    Semin Oncol; 2012 Aug; 39(4):410-33. PubMed ID: 22846859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current clinical uses of the biomarkers for hepatocellular carcinoma.
    Huang J; Zeng Y
    Drug Discov Ther; 2014 Apr; 8(2):98-9. PubMed ID: 24815586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
    Montagnana M; Danese E; Lippi G
    Clin Chim Acta; 2015 May; 445():161-6. PubMed ID: 25840050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma tumour markers: current role and expectations.
    Rich N; Singal AG
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum markers of hepatocellular carcinoma.
    Spangenberg HC; Thimme R; Blum HE
    Semin Liver Dis; 2006 Nov; 26(4):385-90. PubMed ID: 17051452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.